CORDENPHARMA LISBON (PT)
Core Capabilities
- >> Manufacturer of Oral Solid Dosage (OSD) forms (tablets, capsules, sachets & bulk powder)
- >> Manufacturer of non-sterile liquid dosage forms
- >> Extensive primary & secondary packaging capabilities and capacity
- >> Full range of services including manufacturing of clinical & commercial products and pharma-logistics
COMPLIANCE
- >> Infarmed - first inspection 2016
- >> US FDA - first inspection 2021
- >> Brazil (ANVISA) - first inspection 2018
Related Products & Platforms
APIs
Technology Platforms
Facility Legacy
CordenPharma Lisbon is an expert manufacturer of solid oral dosage forms and non-sterile liquid drug products, offering a full range of manufacturing services from phase I-III and commercial scale manufacturing, to packaging and pharma-logistics for a global market.
As a former Vifor Pharma operations site, CordenPharma Lisbon brings over 52 years of experience to CordenPharma’s full-service CDMO platform. The site is inspected by Inframed, FDA and ANVISA.
HISTORY
- >> 1970 - Foundation
- >> 2002 - Expansion of the site
- >> 2006 – Implementation of the Environmental Management System according to ISO 14001
- >> 2009 - Integration into Vifor Pharma
- >> 2018 - Second Production building constructed
- >> 2021 - FDA certification
- >> 2022 - Acquired by ICIG to become Corden Pharma Lisbon S.A.
- >> 2022 - Astorg acquires CordenPharma from ICIG
- >> 2022 - Astorg acquires CordenPharma from ICIG
Managing Director
Rosário Fonseca
Corden Pharma Lisbon S.A.
R. da Indústria, 2
Quinta Grande
2610-088 Amadora
(Apartado 60 001 · 2701-951 Amadora)
Lisboa, Portugal
Phone: +351 21 470 85 00
Fax: +351 21 470 85 06